All general enquiries including upcoming learning modules.
For questions about becoming a PCC member and PCC membership.
Submit a collaboration proposal for PCC’s consideration.
We have a number of virtual workshops planned with the dates to be released soon.
A selection of past events under the PCC umbrella.
To drive the implementation of Comprehensive Genomic Profiling (CGP) and allow all patients with solid tumors access to CGP at time of initial diagnosis, this project aims to provide a detailed analysis of barriers and enablers of CGP in Spain as a pilot country. This first phase will inform a later project to develop tangible strategies to increase access to CGP in Spain, which will have the potential be rolled-out in other countries.
Here is a video summarising the project aims.
PCC-122 • January 2025
The PCC is a non-profit organization dedicated to driving global access to comprehensive genomic testing for all patients with cancer. The PCC is composed of and funded by: AstraZeneca, Bayer, GSK, Johnson & Johnson, Lilly, Novartis, and Roche, at the time of writing.
PCC-176, Date of Review: May 2025